Martek Biosciences resolves patent dispute with Capsugel France

DHA omega-3 innovator and maker of the life'sDHA(TM) brand, Martek Biosciences Corporation (Nasdaq: MATK), announced today it has resolved a patent dispute with Capsugel France. The resolution follows Martek's November 2008 action for infringement filed in the High Court of Strasbourg, France.

As a result of this settlement agreement between Martek and Capsugel France, Capsugel and all of its affiliates have agreed to purchase all of their algal DHA exclusively from Martek for the life of the patent in question. Additionally, Martek and Capsugel will develop a product containing Martek's algal DHA in Capsugel's proprietary Licaps(R) liquid-filled hard capsules.

This settlement agreement between Martek and Capsugel does not include Martek's action against Lonza Ltd AG, which continues.

Source: http://www.martek.com

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.